Company Profile

Biosurface Engineering Technologies Inc (AKA: BioSET)
Profile last edited on: 8/20/07      CAGE: 4MFN1      UEI:

Business Identifier: Develops synthetic peptides for tissue regeneration
Year Founded
2001
First Award
2002
Latest Award
2004
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9430 Key West Avenue Suite 220
Rockville, MD 20850
   (301) 795-6000
   lfinn@biosetinc.com
   www.biosetinc.com
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

Biosurface Engineering Technologies Inc provides biocompatible surface coatings, including drug (growth factors) delivery and thromboresistant stent and vascular graft coatings. The technology can regulate local drug delivery, induce cell apotosis, and attach pharmaceutically active agents to the surface of implantable medical devices to enhance performance

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 1 NIH $99,750
Project Title: Thromboresistant vascular grafts:heparin-peptidomimetics
2003 1 NIH $99,750
Project Title: Radioprotective mimetics of fibroblast growth factors
2002 1 NIH $105,000
Project Title: FGF-Silyl-Heparin Cerebral Aneurysm Coils

Key People / Management

  Thomas G Roueche -- President & CEO

  Bill Mavity -- Former President

  Paul O Zamora -- VP & Chief Scientific Officer

Company News

There are no news available.